Submitted by Anonymous (not verified) on 20 February 2026 - 9:34
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 16, Status: Authorised